These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29578585)

  • 1. Clinical Pharmacokinetics of Sulfobutylether-β-Cyclodextrin in Patients With Varying Degrees of Renal Impairment.
    Hoover RK; Alcorn H; Lawrence L; Paulson SK; Quintas M; Luke DR; Cammarata SK
    J Clin Pharmacol; 2018 Jun; 58(6):814-822. PubMed ID: 29578585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delafloxacin Pharmacokinetics in Subjects With Varying Degrees of Renal Function.
    Hoover RK; Alcorn H; Lawrence L; Paulson SK; Quintas M; Cammarata SK
    J Clin Pharmacol; 2018 Apr; 58(4):514-521. PubMed ID: 29251785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of Intravenous Delafloxacin in Patients With End-Stage Renal Disease.
    Hoover R; Alcorn H; Lawrence L; Paulson SK; Quintas M; Cammarata SK
    J Clin Pharmacol; 2018 Jul; 58(7):913-919. PubMed ID: 29537614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of sulfobutylether-β-cyclodextrin (SBECD) in subjects on hemodialysis.
    Luke DR; Wood ND; Tomaszewski KE; Damle B
    Nephrol Dial Transplant; 2012 Mar; 27(3):1207-12. PubMed ID: 21868395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltration.
    Hafner V; Czock D; Burhenne J; Riedel KD; Bommer J; Mikus G; Machleidt C; Weinreich T; Haefeli WE
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2596-602. PubMed ID: 20368400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy.
    Kiser TH; Fish DN; Aquilante CL; Rower JE; Wempe MF; MacLaren R; Teitelbaum I
    Crit Care; 2015 Feb; 19(1):32. PubMed ID: 25645660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD).
    Luke DR; Tomaszewski K; Damle B; Schlamm HT
    J Pharm Sci; 2010 Aug; 99(8):3291-301. PubMed ID: 20213839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, safety and tolerance of voriconazole in renally impaired subjects: two prospective, multicentre, open-label, parallel-group volunteer studies.
    Abel S; Allan R; Gandelman K; Tomaszewski K; Webb DJ; Wood ND
    Clin Drug Investig; 2008; 28(7):409-20. PubMed ID: 18544001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment.
    Hoover R; Marbury TC; Preston RA; Quintas M; Lawrence LE; Paulson SK; Luke DR; Cammarata SK
    J Clin Pharmacol; 2017 Mar; 57(3):328-335. PubMed ID: 27570245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers.
    Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E
    Clin Ther; 2016 Jan; 38(1):53-65. PubMed ID: 26718605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age.
    Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E
    Clin Ther; 2016 Jan; 38(1):39-52. PubMed ID: 26581327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What Is Old Is New Again: Delafloxacin, a Modern Fluoroquinolone.
    Cho JC; Crotty MP; White BP; Worley MV
    Pharmacotherapy; 2018 Jan; 38(1):108-121. PubMed ID: 29059465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of sematilide in renal failure.
    Shi J; Ripley E; Gehr TW; Sica DA; Dandekar KA; Hinderling PH
    J Clin Pharmacol; 1996 Feb; 36(2):131-43. PubMed ID: 8852389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Dose Pharmacokinetics and Safety of Meropenem-Vaborbactam in Subjects with Chronic Renal Impairment.
    Rubino CM; Bhavnani SM; Loutit JS; Lohse B; Dudley MN; Griffith DC
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose Intravenous Safety, Tolerability, and Pharmacokinetics and Absolute Bioavailability of LCB01-0371.
    Cho YS; Lim HS; Han S; Yoon SK; Kim H; Cho YL; Nam HS; Bae KS
    Clin Ther; 2019 Jan; 41(1):92-106. PubMed ID: 30559004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of renal impairment on the pharmacokinetic profile of intravenous difelikefalin, a kappa opioid receptor agonist for the treatment of pruritus.
    Spencer RH; Noonan PK; Marbury T; Menzaghi F
    BMC Nephrol; 2024 Oct; 25(1):351. PubMed ID: 39402448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ertapenem in patients with varying degrees of renal insufficiency and in patients on hemodialysis.
    Mistry GC; Majumdar AK; Swan S; Sica D; Fisher A; Xu Y; Hesney M; Xi L; Wagner JA; Deutsch PJ
    J Clin Pharmacol; 2006 Oct; 46(10):1128-38. PubMed ID: 16988201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment.
    Kim SH; Kwon JC; Park C; Han S; Yim DS; Choi JK; Cho SY; Lee HJ; Park SH; Choi SM; Choi JH; Yoo JH; Lee DG; Lee JW
    Mycoses; 2016 Oct; 59(10):644-51. PubMed ID: 27324913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of dalbavancin in patients with renal or hepatic impairment.
    Marbury T; Dowell JA; Seltzer E; Buckwalter M
    J Clin Pharmacol; 2009 Apr; 49(4):465-76. PubMed ID: 19318696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and pharmacokinetics of SPR206 in subjects with varying degrees of renal impairment.
    Bruss JB; Bader J; Hamed KA
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0050523. PubMed ID: 37823647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.